ROLE OF FOOD HYPERSENSITIVITY IN ATOPIC DERMATITIS

食物过敏在特应性皮炎中的作用

基本信息

  • 批准号:
    6245304
  • 负责人:
  • 金额:
    $ 2.23万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1997
  • 资助国家:
    美国
  • 起止时间:
    1997-03-05 至 1997-11-30
  • 项目状态:
    已结题

项目摘要

We previously demonstrated that ovomucoid, Gal d 1, is the dominant allergen in hen's egg. Ovomucoid is a highly glycosylated protein comprised of 186 amino acids arranged in 3 tandem domains [Gal d 1.1, 1.2, 1.3], each about 60 amino acids in length. The purpose of this study was to evaluate the allergenic properties of ovomucoid. We isolated the 3 ovomucoid domains by enzymatic digestion and chromatographic purification. Sera from 45 egg allergic patients with atoppic dermatitis were anlyzed by ELISA to determine B cell domain specificity; sera from egg allergic patients were analyzed by inhibition-ELISA to reduce and alkylated, oxidized, and deglycosylated ovomucoid in order to evaluate the importance of linear and conformational structures, and carbohydrate to B cell epitopes. Peripheral blood T cells from 13 egg allergic patients were used to evaluate T-dominant domains and reactivity to reduced and oxidized ovomucoid. Virtually all patients had IgE antibodies to the 3 domains, although there was significalty more IgE activity to Gal d 1.2 [percentage of ovomucoid- specific IgE; median: Gal d 1.2: 40%; Gal d 1.1:23%; Gal d 1.3 26%]. Quantities of patient IgG antibody was comparable to all 3 domains. IgE antibody binding to reduced ovomucoid and IgG binding to oxidized ovomucoid were significantly reduced compared to native ovomucoid [28% and 69%, respectively]. Twenty-one of 33 peripheral blood T cells reacted to Gal d 1.3, 18 of 33 to Gal d 1.2, and 18 of 33 to Gal d 1.1. T cell proliferation in vitro to reduced and oxidized ovomucoid were significantly greater than to the native protein. These results indicate a dichotomy between T cell and B cell comain dominance, and differences in IgE and IgG epitopes. Furthermore results suggest that conformational B cell epitopes play a more significant role in ovomucoid allergenicity in some patients, especially those with "transient" egg hypersensitivity than previously appreciated, and that carbohydrate moieties have a minor effect on allergenicity.
我们以前证明了类卵粘蛋白Gald1是占优势的 鸡蛋中的过敏原。卵粘蛋白是一种高度糖基化的蛋白质 由186个氨基酸组成,排列在3个串联结构域[Gald 1.1, 1.2,1.3],每个约60个氨基酸。这项研究的目的 评价类卵粘蛋白的过敏性。我们分离出了 3个卵粘蛋白结构域的酶切和层析 净化。特应性皮炎鸡蛋过敏患者45例血清分析 用ELISA法分析以确定B细胞域的特异性; 应用抑制-酶联免疫吸附试验对鸡蛋过敏患者进行分析。 烷基化、氧化和脱糖基化的卵粘蛋白 线型和构象结构以及碳水化合物对B的重要性 细胞表位。13例鸡蛋过敏患者外周血T细胞的检测 被用来评估T-优势结构域和对还原和 氧化的卵粘蛋白。 几乎所有患者都有针对这三个区域的IgE抗体,尽管有 IgE活性显著高于Gald 1.2[卵粘蛋白百分比- 特异性IgE;中位数:Gal d 1.2:40%;Gal d 1.1:23%;Gal d 1.3 26%]。 患者免疫球蛋白抗体的量与所有3个区域相当。免疫球蛋白 抗体与还原的卵粘蛋白结合,与氧化的免疫球蛋白结合 与天然卵粘蛋白相比,卵粘蛋白显著减少[28%和 分别为69%]。33个外周血T细胞中有21个对 Gal d 1.3,33中18至Gal d 1.2,33中18至Gal d 1.1。T细胞 体外增殖减少和氧化的卵粘液样物质 明显大于天然蛋白质。 这些结果表明T细胞和B细胞疾病之间存在着二分性。 优势,以及免疫球蛋白和免疫球蛋白表位的差异。进一步的结果 提示构象B细胞表位起着更重要的作用 在一些患者中,特别是在那些有 “暂时性”的鸡蛋超敏反应比之前所认为的要好,而且 碳水化合物对过敏性的影响很小。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Hugh A Sampson其他文献

Standardization of anti-asthma herbal formula MSSM-002 by HPLC chromatographic fingerprint
  • DOI:
    10.1016/s0091-6749(02)81886-3
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Zhong-Mei Zou;Hugh A Sampson;Xiu-Min Li
  • 通讯作者:
    Xiu-Min Li
The Chinese herbal formula, MSSM-002, can reverse the established Th2 phenotype, which is accompanied with down regulation of the th2 transcription factor GATA-3
  • DOI:
    10.1016/s0091-6749(02)81592-5
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Xiu-Min Li;Ariel Teper;Zhong-Mei Zou;Kamal D Srivastava;Brian H Schofield;Hugh A Sampson
  • 通讯作者:
    Hugh A Sampson
Detection of milk proteins in dry powder inhalers containing lactose
  • DOI:
    10.1016/s0091-6749(02)81924-8
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Anna H Nowak-Wegrzyn;Ludmilla Bardina;Kirsten Beyer;Wayne G Shreffler;Hugh A Sampson
  • 通讯作者:
    Hugh A Sampson
Effects of preparation methods on the allergenicity of peanut in a murine model of peanut-induced anaphylaxis
  • DOI:
    10.1016/s0091-6749(02)81676-1
  • 发表时间:
    2002-01-01
  • 期刊:
  • 影响因子:
  • 作者:
    Hayf Emeil Al-Mussawir;Kamal D Srivastava;Kirsten Beyer;Jin-Hua Li;Side Li;Wesley Burks;Gary A Bannon;Xiu-Min Li;Hugh A Sampson
  • 通讯作者:
    Hugh A Sampson
Timing of repeat epinephrine to inform paediatric anaphylaxis observation periods: a retrospective cohort study
重复肾上腺素给药时间以告知儿科过敏反应观察期:一项回顾性队列研究
  • DOI:
    10.1016/s2352-4642(25)00139-7
  • 发表时间:
    2025-07-01
  • 期刊:
  • 影响因子:
    15.500
  • 作者:
    Timothy E Dribin;Hugh A Sampson;Yin Zhang;Stephanie Boyd;Nanhua Zhang;Kenneth A Michelson;Mark I Neuman;David C Brousseau;Rakesh D Mistry;Stephen B Freedman;Paul L Aronson;Kelly R Bergmann;Brittany Boswell;Sri S Chinta;Wee-Jhong Chua;Ari R Cohen;Joanna S Cohen;Alicia Daggett;Justin R Davis;Julia F Freeman;Seth Woolf
  • 通讯作者:
    Seth Woolf

Hugh A Sampson的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Hugh A Sampson', 18)}}的其他基金

Administrative Core
行政核心
  • 批准号:
    8848939
  • 财政年份:
    2013
  • 资助金额:
    $ 2.23万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8364992
  • 财政年份:
    2011
  • 资助金额:
    $ 2.23万
  • 项目类别:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
CTSA 儿科研究基础设施
  • 批准号:
    8364991
  • 财政年份:
    2011
  • 资助金额:
    $ 2.23万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8364993
  • 财政年份:
    2011
  • 资助金额:
    $ 2.23万
  • 项目类别:
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
CTSA 临床试验基础设施
  • 批准号:
    8364990
  • 财政年份:
    2011
  • 资助金额:
    $ 2.23万
  • 项目类别:
MOUNT SINAI INSTITUTES FOR CLINICAL AND TRANSLATIONAL SCIENCES
西奈山临床和转化科学研究所
  • 批准号:
    8364989
  • 财政年份:
    2011
  • 资助金额:
    $ 2.23万
  • 项目类别:
CTSA INFRASTRUCTURE FOR PEDIATRIC RESEARCH
CTSA 儿科研究基础设施
  • 批准号:
    8173753
  • 财政年份:
    2010
  • 资助金额:
    $ 2.23万
  • 项目类别:
Immunologic Responses to Cow's Milk Proteins in IgE-mediated Cow's Milk Allergy
IgE 介导的牛奶过敏中牛奶蛋白的免疫反应
  • 批准号:
    8034293
  • 财政年份:
    2010
  • 资助金额:
    $ 2.23万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8173755
  • 财政年份:
    2010
  • 资助金额:
    $ 2.23万
  • 项目类别:
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
CTSA 艾滋病研究基础设施
  • 批准号:
    8173754
  • 财政年份:
    2010
  • 资助金额:
    $ 2.23万
  • 项目类别:

相似海外基金

Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2022
  • 资助金额:
    $ 2.23万
  • 项目类别:
    Discovery Grants Program - Individual
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10581488
  • 财政年份:
    2022
  • 资助金额:
    $ 2.23万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574979-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 2.23万
  • 项目类别:
    University Undergraduate Student Research Awards
A precision tumor neoantigen identification pipeline for cytotoxic T-lymphocyte-based cancer immunotherapies
用于基于细胞毒性 T 淋巴细胞的癌症免疫疗法的精准肿瘤新抗原识别流程
  • 批准号:
    10332251
  • 财政年份:
    2022
  • 资助金额:
    $ 2.23万
  • 项目类别:
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574984-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 2.23万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574985-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 2.23万
  • 项目类别:
    University Undergraduate Student Research Awards
Modulation of T lymphocyte Activation by ß2-adrenergic Receptor Signalling Pathways
α2-肾上腺素能受体信号通路对 T 淋巴细胞激活的调节
  • 批准号:
    574978-2022
  • 财政年份:
    2022
  • 资助金额:
    $ 2.23万
  • 项目类别:
    University Undergraduate Student Research Awards
Investigating the cell-based activity of a new class of cytotoxic T-lymphocyte antigen-4 (CTLA-4) small molecule inhibitors
研究一类新型细胞毒性 T 淋巴细胞抗原 4 (CTLA-4) 小分子抑制剂的细胞活性
  • 批准号:
    444149
  • 财政年份:
    2021
  • 资助金额:
    $ 2.23万
  • 项目类别:
    Operating Grants
Novel pathways in T lymphocyte differentiation and function
T 淋巴细胞分化和功能的新途径
  • 批准号:
    RGPIN-2015-05491
  • 财政年份:
    2021
  • 资助金额:
    $ 2.23万
  • 项目类别:
    Discovery Grants Program - Individual
Modulation of T lymphocyte Activation by ß2-Adrenergic Receptor Signalling Pathways
通过 α2-肾上腺素能受体信号通路调节 T 淋巴细胞激活
  • 批准号:
    RGPIN-2019-06980
  • 财政年份:
    2021
  • 资助金额:
    $ 2.23万
  • 项目类别:
    Discovery Grants Program - Individual
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了